ZL-2306 (niraparib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZL-2306 (niraparib), covering 2019-01-24 to 2019-01-24. Get the full timeline:
Most recent: Clinical Trial Update: The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer [Phase 1]